Rahul Sarugaser
Stock Analyst at Raymond James
(1.07)
# 3,183
Out of 4,479 analysts
9
Total ratings
25%
Success rate
6.94%
Average return
Main Sectors:
Top Industries:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ONCY Oncolytics Biotech | Initiates: Outperform | $3 | $0.99 | +203.03% | 1 | Apr 4, 2024 | |
| QIPT Quipt Home Medical | Downgrades: Market Perform | $10 | $3.12 | +220.51% | 1 | Feb 16, 2024 | |
| DNA Ginkgo Bioworks Holdings | Downgrades: Market Perform | $2.5 | $0.35 | +621.50% | 3 | Nov 15, 2023 | |
| PROF Profound Medical | Downgrades: Outperform | n/a | $8.58 | - | 2 | Aug 4, 2023 | |
| VFF Village Farms International | Downgrades: Market Perform | $11 → $2.5 | $0.96 | +159.09% | 2 | Feb 27, 2023 |
Oncolytics Biotech
Apr 4, 2024
Initiates: Outperform
Price Target: $3
Current: $0.99
Upside: +203.03%
Quipt Home Medical
Feb 16, 2024
Downgrades: Market Perform
Price Target: $10
Current: $3.12
Upside: +220.51%
Ginkgo Bioworks Holdings
Nov 15, 2023
Downgrades: Market Perform
Price Target: $2.5
Current: $0.35
Upside: +621.50%
Profound Medical
Aug 4, 2023
Downgrades: Outperform
Price Target: n/a
Current: $8.58
Upside: -
Village Farms International
Feb 27, 2023
Downgrades: Market Perform
Price Target: $11 → $2.5
Current: $0.96
Upside: +159.09%